Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Bionime Corporation

Market Cap 4.34B 137M 119M 110M 103M 193M 12.98B 196M 1.3B 506M 6.37B 515M 504M 22.05B P/E 2024
-31x
P/E 2025 -22.2x
Enterprise Value 6.92B 219M 190M 175M 164M 308M 20.67B 312M 2.08B 805M 10.14B 821M 803M 35.12B EV / Sales 2024
3.48x
EV / Sales 2025 3.58x
Free-Float
53.01%
Yield 2024 *
-
Yield 2025 -
1 day+0.72%
1 week+2.93%
Current month-1.58%
1 month-7.26%
3 months-6.64%
6 months-1.40%
Current year-5.55%
1 week 53.9
Extreme 53.9
57.8
1 month 49.75
Extreme 49.75
60
Current year 49.75
Extreme 49.75
72.9
1 year 49.75
Extreme 49.75
73.9
3 years 43.14
Extreme 43.1415
81.92
5 years 43.14
Extreme 43.1415
88.92
10 years 40
Extreme 40.0048
88.92
Manager TitleAgeSince
Chief Executive Officer - 08/07/2010
Director of Finance/CFO - 05/11/2017
Chief Tech/Sci/R&D Officer - 06/11/2018
Director TitleAgeSince
Chairman - 13/04/2003
Director/Board Member - 16/10/2007
Director/Board Member - 14/05/2007
Change 5-day change 1-year change 3-year change Capi.($)
+0.72%+2.93%-16.47%-22.25% 137M
+1.39%-0.78%+161.89%+248.10% 16.89B
-0.51%-4.98%-43.92%-26.63% 9.32B
-1.75%+3.21%+32.60%+16.90% 6.84B
-0.67%+5.31% - - 5.08B
-1.09%-1.61%-26.63%-31.03% 5.02B
-5.74%-1.29%+85.33%+82.20% 4.39B
0.00%-8.71%-31.30%-35.92% 4.09B
+1.20%+5.03%+191.83%-44.71% 4.03B
-1.46%+4.44%-16.74%-42.80% 2.66B
Average -0.79%+1.03%+37.40%+15.98% 5.84B
Weighted average by Cap. -0.45%+0.03%+63.46%+71.54%

Financials

2024 2025
Net sales 1.93B 61.13M 53.07M 48.82M 45.91M 86.04M 5.78B 87.2M 581M 225M 2.83B 229M 225M 9.82B 1.84B 58.12M 50.45M 46.42M 43.66M 81.8M 5.49B 82.91M 552M 214M 2.69B 218M 213M 9.33B
Net income -127M -4.02M -3.49M -3.21M -3.02M -5.66M -380M -5.74M -38.2M -14.81M -186M -15.09M -14.77M -646M -180M -5.7M -4.95M -4.55M -4.28M -8.02M -539M -8.13M -54.14M -20.99M -264M -21.39M -20.93M -915M
Net Debt 2.78B 88.01M 76.4M 70.28M 66.1M 124M 8.32B 126M 836M 324M 4.08B 330M 323M 14.13B 2.57B 81.36M 70.63M 64.97M 61.11M 115M 7.69B 116M 773M 300M 3.77B 305M 299M 13.07B
Logo Bionime Corporation
Bionime Corporation is a Taiwan-based company principally engaged in the manufacture and distribution of blood glucose monitoring products. The Company's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The Company distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.
Employees
-
Date Price Change Volume
17/06/26 56.20 NT$ +0.72% 48,181
16/06/26 55.80 NT$ +1.64% 105,679
15/06/26 54.90 NT$ 0.00% 41,929
12/06/26 54.90 NT$ 0.00% 46,805
11/06/26 54.90 NT$ +0.18% 79,504

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4737 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!